Elderly patients with systolic dysfunction and severe heart failure benefit from an aggressive heart failure treatment program

1999 ◽  
Vol 5 (3) ◽  
pp. 79
Author(s):  
John S. Golden ◽  
Catherine Chelimsky-Fallick ◽  
Donna J. Mateski ◽  
Colleen M. Healey ◽  
Sharon R. Josephson ◽  
...  
Keyword(s):  
Heart Failure ◽  
Elderly Patients ◽  
Treatment Program ◽  
Systolic Dysfunction ◽  
Severe Heart Failure ◽  
Heart Failure Treatment ◽  
Failure Treatment

scholarly journals Rapid Resolution of Acute Fulminant Myocarditis after IVIG and Steroid Treatment

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Michael Barrie ◽  
Lucas McKnight ◽  
Pallavi Solanki
Keyword(s):  
Heart Failure ◽  
Coronary Arteries ◽  
Immunosuppressive Agents ◽  
Viral Myocarditis ◽  
Severe Heart Failure ◽  
Steroid Treatment ◽  
Fulminant Myocarditis ◽  
Unknown Etiology ◽  
Heart Failure Treatment ◽  
Failure Treatment

We report a case of a 59-year-old woman who presented with worsening dyspnea which rapidly progressed to severe heart failure. Coronary arteries showed no obstruction. Supportive measures stabilized the patient’s hemodynamics. Initially intravenous solumedrol was given, but when the patient’s condition continued to deteriorate, intravenous immunoglobulin (IVIG) was added to the treatment regimen and her condition improved. Studies show no benefit to using immunosuppressive agents in viral myocarditis, but benefits have been demonstrated in other etiologies. Patients presenting with acute fulminant myocarditis with unknown etiology that continue to deteriorate with aggressive heart failure treatment may benefit from steroids and IVIG.

scholarly journals Beta-blockers in chronic heart failure in elderly patient

2009 ◽  
Vol 3 (2) ◽  
pp. 89-95
Author(s):  
Alberto De Bernardi
Keyword(s):  
Heart Failure ◽  
Elderly Patient ◽  
Chronic Heart Failure ◽  
Elderly Patients ◽  
Observational Studies ◽  
Randomized Trials ◽  
Beta Blockers ◽  
Young Patients ◽  
Heart Failure Treatment ◽  
Failure Treatment

Chronic heart failure (CHF) is a common and disabling condition with morbidity and mortality that increase dramatically with advancing age. There are evidences, from both randomized trials and observational studies, that suggest that beta-blockers are effective and well tolerated in elderly as well as in young patients. Nonetheless in clinical practice they are substantially underutilized in elderly patients. The article underlines peculiarities of chronic heart failure treatment with beta-blockers in elderly patients, with a review of the most important published trials.

Heart failure treatment program successful in treating health maintenance organization heart failure patients with comorbidities

1999 ◽  
Vol 5 (3) ◽  
pp. 82
Author(s):  
Catherine Chelimsky-Fallick ◽  
John S. Golden ◽  
E.Kirk Huang ◽  
Donna J. Mateski ◽  
Colleen M. Healey ◽  
...  
Keyword(s):  
Heart Failure ◽  
Treatment Program ◽  
Health Maintenance Organization ◽  
Heart Failure Treatment ◽  
Health Maintenance ◽  
Heart Failure Patients ◽  
Failure Treatment

scholarly journals Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1

2015 ◽  
Vol 36 (30) ◽  
pp. 2011-2017 ◽  
Author(s):  
Philippe Menasché ◽  
Valérie Vanneaux ◽  
Albert Hagège ◽  
Alain Bel ◽  
Bernard Cholley ◽  
...  
Keyword(s):  
Heart Failure ◽  
Stem Cell ◽  
Case Report ◽  
Human Embryonic Stem Cell ◽  
Clinical Case ◽  
Embryonic Stem ◽  
Severe Heart Failure ◽  
Heart Failure Treatment ◽  
Cardiac Progenitors ◽  
Failure Treatment
Sign in / Sign up

Export Citation Format

Share Document